Latest News

Simbec-Orion is honoured to have been trusted by Oxford Cannabinoid Technologies to conduct this milestone first-in-human, Phase1 clinical trial of its lead compound, OCT461201 for Postherpetic Neuralgia (PHN) & Irritable Bowel Syndrome. Chief Scientific Officer, Valentino Parravicini recently shared the excitement within OCT in reaching the clinical milestone and the significance of partnering with Simbec-Orion for […]

Simbec-Orion is delighted to share the further expansion of our Clinical Pharmacology Scientific Advisory Board (SAB), with the recent appointment of Dr Kirsty Widenbach. Compared with traditional first-into-human studies, complex early phase studies with umbrella protocols or adaptive designs can offer critical data earlier whilst reducing cost. Such trials require a CRO that is both […]

We are excited to be attending the World Orphan Drug Congress USA in Boston! The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving […]

We are thrilled to share that Alison Hughes, Head of Business Enablement at Simbec-Orion has been recognised as a Veeva Hero,  well done Alison! Alison is a clinic research technology leader, passionate and committed to enabling Simbec-Orion’s growth and success. Working within Simbec-Orion’s core clinical processes, collaborating with numerous sponsors and study sites is not easy […]

AI is entering every stage of pharmacological research, from virtual screening to toxicity prediction, from drug discovery to clinical trial success. AI can speed up, de-risk and accelerate drug development. The various impacts on health, healthcare organizations and economics will be discussed. We will also share our combined experience in the field of AI for […]

The pharmaceutical industry has evolved significantly in the past 40 years. Relatively recent drug developments have seen advancements in cancer treatments, vaccines, antibiotics and more. Such clinical developments have had remarkable impacts on the lives of patients. Though to achieve this, development drugs require huge levels of financial investment. A new drug takes an average […]

Are you attending the Outsourcing in Clinical Trials UK & Ireland meeting in London? This event will bring together attendees from both large and small established pharma alongside biopharmaceutical companies and provide opportunities to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region. Simbec-Orion supports full service, […]